Should a patient who has been taking nortriptyline 20 mg daily for six months taper the medication before discontinuation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, Taper Nortriptyline After 6 Months of Use

A patient on nortriptyline 20 mg daily for 6 months should taper the medication before discontinuation to minimize withdrawal symptoms. While the FDA label does not explicitly mandate tapering 1, tricyclic antidepressants (TCAs) like nortriptyline are known to cause discontinuation syndromes when stopped abruptly, and physical dependence can develop within weeks to months of use 2, 3.

Why Tapering is Necessary

After 6 months of daily use, physical dependence has likely developed. Discontinuation symptoms with TCAs include:

  • Gastrointestinal distress (nausea, vomiting)
  • Flu-like symptoms (fatigue, myalgia, chills)
  • Sensory disturbances
  • Sleep disruption
  • Psychological symptoms (anxiety, irritability, crying spells)

These symptoms typically emerge within days of stopping and can be distressing enough to cause missed work and decreased productivity 2, 3. A prospective pediatric study found that gradual tapering of nortriptyline prevented withdrawal symptoms in most patients, with only 5 of 30 subjects experiencing brief gastrointestinal distress 4.

Recommended Tapering Strategy

Use a hyperbolic (proportionate) taper rather than linear dose reductions:

  • Initial reduction: Decrease by 25% of current dose (20 mg → 15 mg) and hold for 2-4 weeks
  • Subsequent reductions: Reduce by 25% of the most recent dose every 2-4 weeks
    • 15 mg → 11 mg → 8 mg → 6 mg → 4.5 mg → 3 mg, etc.
  • Monitor closely after each reduction for withdrawal symptoms
  • Slow or pause if significant symptoms emerge

This approach is based on recent evidence showing that hyperbolic tapering produces more consistent pharmacological effects at each step compared to linear reductions 5, 6. While these principles are best established for benzodiazepines [7-7], the same pharmacological rationale applies to antidepressants 5, 3.

Practical Implementation

At 20 mg daily, you can achieve proportionate reductions by:

  • Using liquid formulation if available for precise dosing at lower doses
  • Cutting tablets (if scored) for intermediate doses
  • Requesting compounded formulations for very small final doses

Total taper duration: Expect 8-16 weeks minimum for this dose and duration of use. Some patients may require slower tapering (months) if withdrawal symptoms are significant 5.

Key Monitoring Points

  • Check in with the patient 1-2 weeks after each dose reduction
  • Watch for emergence of withdrawal symptoms (GI upset, anxiety, sleep disturbance)
  • If intolerable symptoms occur, return to the previous dose temporarily, then attempt smaller reductions (10-15% instead of 25%)
  • Continue monitoring for 2-4 weeks after complete discontinuation for late-emerging symptoms

Important Caveat

Do not abruptly discontinue. The 20 mg dose is relatively low, but 6 months is sufficient time for physical dependence to develop. The minor inconvenience of a gradual taper far outweighs the risk of a distressing discontinuation syndrome that could undermine the patient's confidence in future medication changes 2, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.